WALTHAM, Mass. – PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will showcase technologies and services at the Analytica 2012 conference in Munich, Germany, April 17-20, at the New Munich Trade Fair Centre, Booth 401, Hall 2. PerkinElmer’s innovative solutions provide customers […]
Dotmatics Limited, a leading provider of drug discovery informatics solutions and services, is pleased to announce the addition of Dr. Mariana Vaschetto to their Business Development Team. Dr. Vaschetto will serve as Vice President of Business Development and Marketing for Europe, Middle East, Africa and Latin America and will strengthen the growth and expansion of […]
Ipswich, Mass. – New England Biolabs, Inc. (NEB), an industry leader in the discovery and production of enzymes for molecular biology applications, has been granted ISO 13485:2003 certification for its design, development and distribution of standard and custom molecular biology and related reagents across applications in academic and industrial research. ISO 13485:2003 is the established […]
ALISO VIEJO, Calif., SOUTH SAN FRANCISCO, Calif. – Ambry Genetics, a global leader in clinical diagnostics and genomic services, announced today the launch of Fluidigm (NASDAQ:FLDM) BioMark™ HD and Access Array™ System-based genomic research services. These services provide gene expression, SNP genotyping, and sample preparation for targeted sequencing using next-generation sequencers, focused on the genomics […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) released the following statement regarding its pending offer for Illumina, Inc. (NASDAQ: ILMN): “We continue to believe that on the basis of the public information that has been available to us, our offer price of $51 per share is full, fair and extremely attractive by every conceivable financial metric. […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE Amex:BTX) today announced that its Board of Directors has recently formed a Science and Technology Committee to oversee the development and commercialization of BioTime’s technology and products in regenerative medicine and oncology. The three-member committee will work with officers and employees of BioTime and its subsidiaries to oversee the execution […]
Aarhus, Denmark — April 12, 2012 — In order to simplify the product portfolio, CLC bio announced today that the company has trimmed away the niche desktop software packages CLC DNA Workbench, CLC RNA Workbench, and CLC Protein Workbench. All features from these three niche workbenches are incorporated into a single commercial workbench for traditional […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) today sent an open letter to shareholders of Illumina, Inc. (NASDAQ: ILMN) urging them to vote the GOLD proxy card for Roche’s independent director nominees and other proposals at the 2012 Illumina annual meeting to be held on 18 April 2012. About the Offer On January 27, 2012, Roche […]
LANCASTER, Calif.– Simulations Plus, Inc. (NASDAQ: SLP – News ), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that further testing shows that the newest molecule the Company has designed to inhibit the malaria parasite is nearly three times more potent as an inhibitor of the drug-sensitive 3D7 […]
WALTHAM, Mass — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has opened a new demonstration laboratory and training center in Seoul, South Korea. The facility, which will showcase the company’s industry-leading offering of analytical instrumentation, software and consumables, strengthens Thermo Fisher’s foothold in this important emerging market. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
